Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience.
Değerli E, Derin S, Oruç K, Şengül Samancı N, Bedir Ş, Çelik E, Şentürk Öztaş N, Alkan G, Demirelli FH, Demirci NS. Değerli E, et al. Among authors: senturk oztas n. J Med Virol. 2021 Oct;93(10):5839-5845. doi: 10.1002/jmv.27123. Epub 2021 Jun 12. J Med Virol. 2021. PMID: 34081337 Free PMC article.
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
Yekedüz E, Tural D, Ertürk İ, Karakaya S, Erol C, Ercelep Ö, Arslan Ç, Sever ÖN, Kılıçkap S, Şentürk Öztaş N, Küçükarda A, Can O, Öksüzoğlu B, Şendur MA, Karadurmuş N, Ürün Y. Yekedüz E, et al. Among authors: senturk oztas n. J Cancer Res Clin Oncol. 2022 Dec;148(12):3537-3546. doi: 10.1007/s00432-022-04055-5. Epub 2022 May 26. J Cancer Res Clin Oncol. 2022. PMID: 35616728
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
Yekedüz E, Karakaya S, Ertürk İ, Tural D, Uçar G, Şentürk Öztaş N, Arıkan R, Hızal M, Küçükarda A, Sever ÖN, Arslan Ç, Can O, Kılıçkap S, Yazgan C, Karadurmuş N, Şendur MA, Çiçin İ, Demirci U, Özgüroğlu M, Öksüzoğlu B, Ürün Y. Yekedüz E, et al. Among authors: senturk oztas n. Clin Genitourin Cancer. 2023 Feb;21(1):175-182. doi: 10.1016/j.clgc.2022.07.006. Epub 2022 Jul 16. Clin Genitourin Cancer. 2023. PMID: 35970759
Prognostic factors in Kaposi sarcoma, single centre experience.
Değerli E, Oruç K, Şentürk Öztaş N, Alkan Şen G, Bedir Ş, Demirci NS, Demirelli HF. Değerli E, et al. Among authors: senturk oztas n. Australas J Dermatol. 2024 Aug;65(5):444-450. doi: 10.1111/ajd.14309. Epub 2024 May 17. Australas J Dermatol. 2024. PMID: 38760927
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Erol C, Yekedüz E, Tural D, Karakaya S, Şentürk Öztaş N, Uçar G, Kılıçkap S, Ertürk İ, Sever ÖN, Arslan Ç, Küçükarda A, Can O, Balvan Ö, Yazgan SC, Özgüroğlu M, Öksüzoğlu B, Şendur MAN, Ürün Y. Erol C, et al. Among authors: senturk oztas n. Urol Int. 2023;107(6):595-601. doi: 10.1159/000528994. Epub 2023 Mar 30. Urol Int. 2023. PMID: 36996793